Unit 1 Flashcards
Gibbs Free Energy under non-standard conditions
ΔG=ΔG0’+RTln([products]/[reactants]
Gas Constant
R is the gas constant:1.987 cal/mol ºK.
Gibbs Free Energy related to equilibrium constant
ΔG0’ = -RT log K’eq cal/mol
or possibly ln
Gibbs Free energy of redox reaction
ΔG’o = -nF ΔE’o
Faraday Constant
96,500 joules/volt mol
Difference between DNA and RNA nucleotides
DNA is missing a -OH on the 2’ ribose carbon
Nucleotide
- nucleotide: base-sugar-phosphate
Nucleoside
nucleoside: base-sugar (e.g.: deoxyadenosine)
Base
A/T/C/G/U
Solubility of Nucleotides
pyrimidines > purines; nucleotides > nucleosides > bases
Gout and Lesch-Nyhan Disease
buildup of purines in our tissues. Purines are the least soluble = tissues that have these buildups have gross cellular defects
AZT and DDI
Act as chain terminators (mimics nucleotide but doesn’t have 3’ OH. DDI (dideoxyinosine) can be used to inhibit HIV reverse transcriptase activity) AZT=Azidothymidine
Avery, Cloud, and Mccarty
discovered that DNA is the important information carrier in our cells (live/dead virulent/nonvirulent experiments with mice)
Chargaff’s Rule
Base pairing!
Handedness of Helices in DNA
Right!
Base pairs per turn of helix
10
Nitrosamine
Converted to nitrous acid, a deaminating agent that causes mutations, found in cigarette smoke
Puromycin function
an antibiotic that mimics the 3’ acceptor end of a tRNA that has an amino acid. It binds in the ribosome as it is translating & covalently attaches to a growing polypeptide chain –> terminates chain, prevents completion of translation.
Cisplatin
Base alkylating agent (cancer)
Actinomycin D and doxorubicin
a naturally occurring antibiotic that has also been used as a chemotherapy. “Intercalates”
into DNA (inserts a ring structure that can stack with DNA bases) and alters the double-helical structure.
Interferes with DNA replication and transcription
Etoposide and Camptothecin
chemotherapeutics that target topoisomerases that relax DNA supercoiling
(super-twisting of the double-helix). Topoisomerases are necessary during DNA replication to avoid
supercoiling as the double helix is opened up to copy the strands. Topoisomerases must break the DNA
backbone to “relax” supercoiled DNA. Drugs that interfere with this process usually leave DNA breaks that
cannot be repaired
Change-causing mutations
- Uncorrected replication errors
- Depurination
- Deamination
- Alkylation
- Pyrimidine Dimers
- Reactive Oxidative Species
- Base adducts
Depurination
Purine (A/G) is removed, leaving only sugar phosphate backbone (unstable)
Deamination
Amine group is removed from cC to form a U, which will then be base paired with A/T
Alkylation
Addition of a methyl group to the sixth oxygen on guanine–> O6-methylguanine
Pyrimidine Dimers
Thymine-thymine double bonds
Base adducts
BPDE addition to guanosine results in base matching with A by DNA pol
Direct Reversal of DNA Damage
1) repair of nick caused by DNA ligase in phosphodiester backbone
2) Removal of methyl from 6-O-methyl guanosine by MGMT
Mismatch Repair (MMR)
MutS and Mut L (prokaryotes) or MSH/MLH (Eukaryotes) scan strands and bind when they find an error. Then helicase unwinds, endonuclease cleaves, oligonucleotide is excised, polymerase refills, ligase seals.
New strand is ID’d in Eukaryotes by increased number of nicks.
Base Excision Repair (BER)
*For mutations that are do not cause structural changes in DNA and are not targeted by Nucleotide excision Repair (ex. C–> U or methylation)
Depends on glycosylase, which cuts the wrong base away from the phosphosugar backbone. The abasic site is then removed by 2 endonucleases (3’ and 5’ cuts), refilled by DNA Pol, and sealed by ligase.
Nucleotide Excision Repair (NER)
*Corrects issues that distort DNA structure and block polymerase function (ex. thymine dimers and BPDE base adducts)
Distorted DNA is recognized by protein complex that binds. Helicase unwinds (part of TFIIH complex) and endonucleases cut either sides of ~30 bp oligonucleotide. Pol fills in gap, ligase sease.
Diseases caused by mutation in NER genes
xeroderma pigmentosum, cockayne syndrome, tricothiodystrophy
Repair pathway for big mutations that cannot be fixed by NER
Trans-lesion synthesis
Protein Kinases important for DNA damage checkpoint
ATM and ATR
Mismatch repair defect associated disease
hereditary non-polyposis colorectal cancer
DNA Polymerase I
helps correct & repair DNA. Replaces the RNA primer with DNA: has 5’-3’ exonuclease activity to remove RNA, then 5’-3’ polymerase activity to fill in the gap.
DNA Polymerase III
MAJOR REPLICATIVE ENZYME – has a sliding clamp that keeps it attached to DNA over long distances
RNA Polymerase I
Makes ribosomal RNA= is the busiest of the all the pols – makes over 90% of the RNA in our cells
RNA Pol II
mRNA, snRNA, miRNA, lncRNA
- has unique C-terminal domain (CTD) on large subunit
o This binds to proteins that help regulate elongation & processing of the mRNA transcript
RNA Pol III
tRNA
E Coli Polymerase
1 type of polymerase for everything
alpha-amantin
a toxin found in mushrooms. Binds to RNA pol II at the site of the bridge helix. Prevents translocation, elongation of the growing mRNA chain –> kills you
rifampicin
Antibiotic: binds bacterial RNA polymerase and blocks the RNA exit channel
Components of RNA Pol II initiation complex
TFIIA, TFIIB, TFIID (TATA-binding protein), TFIIE (also has helicase activity and ATPase), TFIIH(also participates in NER, acts as helicase.
CDK7 (Part of TFIIH) phosphorylates CTD on RNA Pol II during promoter clearance
TATA binding protein function
TBP binds in minor groove and directs assembly of initiation complex
5’ Capping Steps
1) remove triphosphate on 5’ end with triphosphatase
2) Transfer GTP to the chain backwards (5’-5’) with guanylyltransferase
3) Methylate GTP with guanylyl-7-methyl transferase
Purposes of 5’ cap
1) removes 5’ triphosphate
2) makes 5’ end resistant to exonucleases
3) Helps with splicing and processing with cap-binding complex
4) Translation factor eIF4E recognizes cap and transports mRNA to ribosomes
5) degradation of 5’ cap is a sign for mRNA degradation
Conserved sequences in introns
5’ GU……..A……………AG 3’
Genetic Disorders caused by Splicing
Marfan’s syndrome - mutations in fibrillin transcript. They are tall and prone to aneurysms
Abnormal splicing of CD44 gene promotes tumor metastasis
Binding sites of snRNA’s in splicing
1) u1snRNA==>5’ GU
2) u2 snRNA ==> Branch point A
3) u2AF snRNA ==> 3’ AG
Termination Codons
UAG, UGA, UAA
poly A site consensus sequence
AAUAAA
Poly-A tail formation
1) new mRNA is cleaved at the Poly-A consensus sequence
2) Poly-A tail is added and capped with PAB (poly-A-binding protein)
Poly-A tail functions
1) Protection from degradation
2) export from nucleus
* cancer cells often have shorter polyA tails to avoid detection
Overexpression of EIF4E
Leads to malignant transformation
Treatment of Spinal Muscular Atrophy
Rescue of SMN1 mutations by altering splice sites
alpha-Thallasemia
Several types of anemias. Can be caused by mutation of AAUAAA or mutation of gene in beta-gobin promoter
-Mutations also often disrupt alpha helix structure
Hemophilia-B-Leyden
X-linked disorder that involves clotting
Mutation in Promoter IX gene
Androgen receptor can bind nearby and promote translation, so before puberty they only make 1% of factor IX and after puberty they make 60% of normal factor IX
Fragile X syndrome
CGG repeats in the FMR1 gene, leading to increased methylation of the cytosine (CpG) and increased gene silencing
Targets for drugs attacking DNA metabolism
- Synthesis of precursors (dNTP)
- Intercalation (getting in the middle)
- Covalently binding bps
- Topoisomerases
Craniosynostosis
Defect of homeodomain protein that binds too tightly to MSX2 gene, leading to premature closure of skull
Gain of fxn
Androgen Insensitivity Syndrome
Mutation of DNA-binding region or ligand (androgen) domain of androgen binding protein, a zinc finger DNA binding protein. Secondary sex characteristics are not developed and person may be infertile
Waardenburg Syndrome Type II
Mutation in a gene for a transcription factor that plays a role in development of melanocytes. Characterized by deafness and pigmentation anomolies